Public Employees Retirement System of Ohio maintained its stake in Pharmerica Corporation (NYSE:PMC) during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 4,552 shares of the company’s stock at the end of the first quarter. Public Employees Retirement System of Ohio’s holdings in Pharmerica Corporation were worth $107,000 as of its most recent SEC filing.

Several other large investors also recently bought and sold shares of the company. BlackRock Inc. raised its stake in Pharmerica Corporation by 51,604.4% in the first quarter. BlackRock Inc. now owns 3,975,551 shares of the company’s stock valued at $93,027,000 after buying an additional 3,967,862 shares during the period. Sessa Capital IM L.P. bought a new stake in Pharmerica Corporation during the first quarter valued at approximately $11,968,000. Norges Bank bought a new stake in Pharmerica Corporation during the fourth quarter valued at approximately $3,864,000. Citadel Advisors LLC raised its stake in Pharmerica Corporation by 78.9% in the first quarter. Citadel Advisors LLC now owns 338,128 shares of the company’s stock valued at $7,912,000 after buying an additional 149,142 shares during the period. Finally, Bank of America Corp DE raised its stake in Pharmerica Corporation by 59.7% in the first quarter. Bank of America Corp DE now owns 391,996 shares of the company’s stock valued at $9,173,000 after buying an additional 146,560 shares during the period. Hedge funds and other institutional investors own 94.25% of the company’s stock.

Shares of Pharmerica Corporation (PMC) traded down 0.17% on Thursday, reaching $29.00. 101,006 shares of the company traded hands. Pharmerica Corporation has a 1-year low of $19.20 and a 1-year high of $29.10. The company has a 50-day moving average of $26.89 and a 200-day moving average of $25.01. The stock has a market capitalization of $902.51 million, a price-to-earnings ratio of 39.30 and a beta of 0.92.

Pharmerica Corporation (NYSE:PMC) last released its quarterly earnings data on Wednesday, August 2nd. The company reported $0.47 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.47. Pharmerica Corporation had a net margin of 1.05% and a return on equity of 10.94%. The company had revenue of $592 million during the quarter, compared to analysts’ expectations of $592.96 million. During the same quarter in the previous year, the company earned $0.47 earnings per share. The firm’s revenue for the quarter was up 13.9% on a year-over-year basis. Analysts anticipate that Pharmerica Corporation will post $1.92 earnings per share for the current fiscal year.

WARNING: This news story was originally published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this news story on another publication, it was illegally copied and republished in violation of U.S. & international copyright and trademark law. The original version of this news story can be read at https://www.thecerbatgem.com/2017/08/17/public-employees-retirement-system-of-ohio-has-107000-position-in-pharmerica-corporation-pmc.html.

Several equities research analysts have recently commented on PMC shares. ValuEngine lowered Pharmerica Corporation from a “buy” rating to a “hold” rating in a research note on Friday, June 2nd. Zacks Investment Research lowered Pharmerica Corporation from a “buy” rating to a “hold” rating in a research note on Friday, June 23rd. Credit Suisse Group lowered Pharmerica Corporation from an “outperform” rating to a “neutral” rating and upped their price objective for the stock from $29.00 to $29.25 in a research note on Friday, August 4th. They noted that the move was a valuation call. BidaskClub downgraded shares of Pharmerica Corporation from a “hold” rating to a “sell” rating in a report on Monday, July 31st. Finally, Barrington Research downgraded shares of Pharmerica Corporation from an “outperform” rating to an “underperform” rating in a report on Thursday, August 3rd. Two equities research analysts have rated the stock with a sell rating, four have assigned a hold rating and one has issued a buy rating to the company’s stock. Pharmerica Corporation currently has a consensus rating of “Hold” and a consensus target price of $28.83.

Pharmerica Corporation Company Profile

Want to see what other hedge funds are holding PMC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Pharmerica Corporation (NYSE:PMC).

Institutional Ownership by Quarter for Pharmerica Corporation (NYSE:PMC)

Receive News & Stock Ratings for Pharmerica Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharmerica Corporation and related stocks with our FREE daily email newsletter.